BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1316071)

  • 21. Effects of enrofloxacin on porcine phagocytic function.
    Schoevers EJ; van Leengoed LA; Verheijden JH; Niewold TA
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2138-43. PubMed ID: 10471554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes.
    Taira K; Koga H; Kohno S
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1877-81. PubMed ID: 8239600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
    Stuht H; Lode H; Koeppe P; Rost KL; Schaberg T
    Antimicrob Agents Chemother; 1995 May; 39(5):1045-9. PubMed ID: 7625786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
    Velpandian T; Gupta SK; Gupta YK; Agarwal HC; Biswas NR
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):505-11. PubMed ID: 10609773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F; Takahashi T; Morita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of antiinflammatory agents on the accumulation of ofloxacin in human polymorphonuclear leukocytes].
    Orero A; Cantón E; Bermejo MV; Velert MM; Cabrera E; Pemán J; Gobernado M
    Rev Esp Quimioter; 1999 Jun; 12(2):144-8. PubMed ID: 10562676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    Ono C; Tanaka M
    J Pharm Pharmacol; 2003 Aug; 55(8):1127-33. PubMed ID: 12956903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes.
    Aoki M; Ono Y; Kunii O; Goldstein E
    J Antimicrob Chemother; 1994 Sep; 34(3):383-90. PubMed ID: 7829412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes.
    Ozaki M; Komori K; Matsuda M; Yamaguchi R; Honmura T; Tomii Y; Nishimura I; Nishino T
    Antimicrob Agents Chemother; 1996 Mar; 40(3):739-42. PubMed ID: 8851603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of norfloxacin and lomefloxacin in aqueous humour analysed by microdialysis].
    Sato H; Fukuda S; Inatomi M; Koide R; Uchida N; Kanda Y; Kiuchi Y; Oguchi K
    Nippon Ganka Gakkai Zasshi; 1996 Jul; 100(7):513-9. PubMed ID: 8741334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of ion pump-inhibiting drugs on the accumulation of ofloxacin and grepafloxacin in human polymorphonuclear leukocytes].
    Orero A; Cantón E; Pemán J; Velert MM; Bermejo MV
    Rev Esp Quimioter; 2002 Dec; 15(4):352-9. PubMed ID: 12587041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lomefloxacin: microbiologic assessment and unique properties.
    Mayer KH; Ellal JA
    Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The uptake of fluoroquinolone agent drugs by cultured human conjunctival epithelial cells and cultured SIRC rabbit corneal cells].
    Fukuda M; Yoshitake Y; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1999 Aug; 103(8):576-9. PubMed ID: 10466328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of antimicrobial agents on the uptake of ofloxacin and its optically active isomer (-)-ofloxacin by human polymorphonuclear leucocytes.
    Pascual A; García I; Perea EJ
    J Antimicrob Chemother; 1991 Nov; 28(5):727-30. PubMed ID: 1778875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.